Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals

被引:0
作者
Freitas, Marta [1 ]
Andrade, Paulo [2 ,3 ]
Pinto, Ricardo [4 ]
Trigo, Fernanda [4 ]
Azevedo, Ana [1 ,5 ,6 ]
Almeida, Francisco [1 ,2 ,6 ]
机构
[1] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200039 Porto, Portugal
[2] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, Unidade Prevencao & Controlo Infecao & Resistencia, P-4200319 Porto, Portugal
[3] Unidade Local Saude Sao Joao, Serv Doencas Infecciosas, P-4200319 Porto, Portugal
[4] Unidade Local Saude Sao Joao, Serv Hematol Clin, P-4200319 Porto, Portugal
[5] Unidade Local Saude Sao Joao, Ctr Epidemiol Hosp, P-4200319 Porto, Portugal
[6] Univ Porto, Inst Saude Publ, Lab Invest Integrat & Translac Saude Populac ITR, EPIUnit, P-4050600 Porto, Portugal
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
febrile neutropenia; high risk; antimicrobial stewardship; survey; guidelines; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OUTPATIENT MANAGEMENT; FEVER; RESISTANCE; ONCOLOGY; THERAPY;
D O I
10.3390/antibiotics13090822
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Febrile neutropenia (FN) is a potentially severe entity, particularly in hemato-oncologic patients who have higher incidence of colonization with multidrug-resistant bacteria. Discrepancies among guidelines contribute to divergence in antimicrobial practices. Our objective was to assess the variation of practices in antimicrobial therapy in high-risk FN among Portuguese hematologists. Methods: We conducted a cross-sectional study through the implementation of an online survey, open to all clinical hematologists in the country. To characterize practice patterns regarding critical elements in FN management, three clinical vignettes were designed to describe typical situations where narrow-spectrum empiric antibiotics (vignette 1), short-course therapy (vignette 2) and de-escalation (vignette 3) could be performed. The remaining questions characterized clinical experience, department size, and differentiation and decision-making process regarding FN antibiotic therapy. Results: The survey yielded 31 responses from 11 hospitals across four regions. All respondents opted for empiric narrow-spectrum antibiotics, 22.6% opted for short-course therapy (mostly senior specialists from larger settings) and 35.5% for de-escalation (mostly young specialists). Availability of an FN protocol seemed to favor both approaches. These findings should be complemented by qualitative assessments of barriers to best practices and should support the need for interventions to improve antibiotic use in febrile neutropenia.
引用
收藏
页数:13
相关论文
共 26 条
  • [1] Evidence of self-report bias in assessing adherence to guidelines
    Adams, AS
    Soumerai, SB
    Lomas, J
    Ross-Degnan, D
    [J]. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 1999, 11 (03) : 187 - 192
  • [2] Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
    Aguilar-Guisado, Manuela
    Espigado, Ildefonso
    Martin-Pena, Almudena
    Gudiol, Carlota
    Royo-Cebrecos, Cristina
    Falantes, Jose
    Vazquez-Lopez, Lourdes
    Isabel Montero, Maria
    Rosso-Fernandez, Clara
    de la Luz Martino, Maria
    Parody, Rocio
    Gonzalez-Campos, Jose
    Garzon-Lopez, Sebastian
    Calderon-Cabrera, Cristina
    Barba, Pere
    Rodriguez, Nancy
    Rovira, Montserrat
    Montero-Mateos, Enrique
    Carratala, Jordi
    Antonio Perez-Simon, Jose
    Miguel Cisneros, Jose
    [J]. LANCET HAEMATOLOGY, 2017, 4 (12): : E573 - E583
  • [3] Behavioral Components and Context of Antimicrobial Prescription in a Tertiary Hospital in Portugal
    Almeida-Costa, Ana Paula Muniz
    Paiva, Jose-Artur
    Almeida, Antonio Jorge Santos
    Barbosa, Elisabete
    Correia, Sofia
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (06):
  • [4] European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
    Averbuch, Diana
    Orasch, Christina
    Cordonnier, Catherine
    Livermore, David M.
    Mikulska, Malgorzata
    Viscoli, Claudio
    Gyssens, Inge C.
    Kern, Winfried V.
    Klyasova, Galina
    Marchetti, Oscar
    Engelhard, Dan
    Akova, Murat
    [J]. HAEMATOLOGICA, 2013, 98 (12) : 1826 - 1835
  • [5] Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
    Boccia, Ralph
    Glaspy, John
    Crawford, Jeffrey
    Aapro, Matti
    [J]. ONCOLOGIST, 2022, 27 (08) : 625 - 636
  • [6] Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study
    De Bus, Liesbet
    Denys, Wouter
    Catteeuw, Julie
    Gadeyne, Bram
    Vermeulen, Karel
    Boelens, Jerina
    Claeys, Geert
    De Waele, Jan J.
    Decruyenaere, Johan
    Depuydt, Pieter O.
    [J]. INTENSIVE CARE MEDICINE, 2016, 42 (06) : 1029 - 1039
  • [7] Excellence, 2012, NIfHaC Neutropenic Sepsis: Prevention and Management in People with Cancer: Clinical Guideline CG151: National Institute for Health and Care Excellence
  • [8] Communicating Safe Outpatient Management of Fever and Neutropenia
    Flowers, Christopher R.
    Karten, Clare
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (04) : 207 - 210
  • [9] Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147
  • [10] Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
    Heinz, W. J.
    Buchheidt, D.
    Christopeit, M.
    von Lilienfeld-Toal, M.
    Cornely, O. A.
    Einsele, H.
    Karthaus, M.
    Link, H.
    Mahlberg, R.
    Neumann, S.
    Ostermann, H.
    Penack, O.
    Ruhnke, M.
    Sandherr, M.
    Schiel, X.
    Vehreschild, J. J.
    Weissinger, F.
    Maschmeyer, G.
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (11) : 1775 - 1792